CM
ABBV icon

Caption Management’s AbbVie ABBV Stock Holding History

Caption Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8M Buy
+47,000
New +$10.1M 0.06% 354
2025
Q4 		– Sell
-211,100
Closed -$48.9M – 1518
2025
Q3 		$48.9M Buy
+211,100
New +$43M 0.38% 46
2025
Q1 		– Sell
-222,200
Closed -$39.5M – 1444
2024
Q4 		$39.5M Buy
222,200
+172,200
+344% +$31.7M 0.37% 40
2024
Q3 		$9.87M Hold
50,000
– – 0.16% 156
2024
Q2 		$8.58M Hold
50,000
– – 0.13% 171
2024
Q1 		$9.11M Sell
50,000
-55,000
-52% -$9.48M 0.14% 185
2023
Q4 		$16.3M Buy
105,000
+50,000
+91% +$7.29M 0.22% 115
2023
Q3 		$8.2M Hold
55,000
– – 0.13% 193
2023
Q2 		$7.41M Buy
55,000
+15,000
+38% +$2.2M 0.13% 201
2023
Q1 		$6.37M Buy
+40,000
New +$6.12M 0.12% 192
2022
Q3 		– Sell
-126,900
Closed -$19.4M – 1458
2022
Q2 		$19.4M Buy
126,900
+63,400
+100% +$9.69M 0.27% 84
2022
Q1 		$10.3M Sell
63,500
-136,500
-68% -$19.8M 0.12% 209
2021
Q4 		$27.1M Buy
200,000
+100,000
+100% +$11.8M 0.3% 62
2021
Q3 		$10.8M Buy
+100,000
New +$11.4M 0.12% 219
2021
Q1 		– Sell
-86,900
Closed -$9.31M – 993
2020
Q4 		$9.31M Buy
86,900
+24,800
+40% +$2.38M 0.21% 130
2020
Q3 		$5.44M Sell
62,100
-21,900
-26% -$2.06M 0.13% 201
2020
Q2 		$8.25M Buy
+84,000
New +$7.4M 0.27% 87
2019
Q3 		– Sell
-40,000
Closed -$2.91M – 681
2019
Q2 		$2.91M Sell
40,000
-25,000
-38% -$1.96M 0.15% 192
2019
Q1 		$5.24M Buy
+65,000
New +$5.32M 0.29% 102

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Caption Management's ABBV Position: Q2 2026 in Review

Caption Management sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 33,700 shares — an estimated $7.25M sold.

Caption Management first reported a position in ABBV in Q1 2019 and held it in 8 quarters. The position peaked at $10.2M in Q4 2021. 4,217 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Caption Management reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Caption Management sold 33,700 AbbVie shares in Q2 2026, an estimated $7.25M.
  • Caption Management first reported a position in AbbVie in Q1 2019 and held it in 8 quarters.
  • Caption Management's AbbVie position peaked at $10.2M in Q4 2021.
  • 4,217 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.